NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)

Closed Posted

Opportunity number
PAR-23-286
Agency
Applications due
Award size
Not on record

Opportunity facts

Assistance listings
Funding instrument
Grant
Categories
  • Health
  • Education
Eligible applicants
  • City/Township Governments
  • Tribal Organizations (Not Federally Recognized)
  • Non-501(c)(3) Nonprofits
  • Other
  • State Governments
  • Small Businesses
  • Special District Governments
  • For Profit Organizations
  • Public or Indian Housing Auth.
  • Independent School Districts
  • Tribal Governments (Federally Recognized)
  • Higher Education Inst. (Private)
  • Higher Education Inst. (Public)
  • 501(c)(3) Nonprofits
  • County Governments
Points of contact
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

Written by GovTribe AI ·

The National Institutes of Health National Cancer Institute is soliciting applications for the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed), a grant program with an application due date of October 14, 2026. Applicants proposing to lead independent clinical trials, clinical trial feasibility studies, or ancillary clinical trials are ineligible under this NOFO; candidates intending to serve as lead investigators on such trials must apply to companion NOFOs (PAR-23-287 or PAR-23-288).

Eligible applicants include universities, colleges, hospitals, nonprofit organizations, for-profit entities, faith-based and community-based organizations, federal agencies, HBCUs, Hispanic-serving institutions, tribal governments (federally recognized and other), Alaska Native and Native Hawaiian serving institutions, AANAPISIs, TCCUs, and U.S. territories or possessions. Non-domestic entities and foreign components of U.S. organizations are ineligible, though foreign components as defined in the NIH Grants Policy Statement are permitted. Selected awardees must be U.S. citizens or permanent residents.

The program targets postdoctoral fellows with research or clinical doctoral degrees who do not require extended mentored training. Researchers in cancer control, cancer prevention, and cancer data sciences are especially encouraged to apply. The award provides up to five years of support combining mentored and independent research phases designed to facilitate transition to tenure-track or equivalent faculty positions. Candidates may participate in clinical trials led by mentors or co-mentors but cannot serve as independent clinical trial leads.

Applications undergo scientific peer review followed by National Cancer Advisory Board evaluation, with approximately ten-month review timelines. The program operates under Assistance Listing 93.398 (Cancer Research Manpower).

Synopsis

The purpose of the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) program is to increase and maintain a strong cohort of new and talented, NCI-supported, independent investigators. This program is designed for postdoctoral fellows with research and/or clinical doctoral degrees who do not require an extended period of mentored research training beyond their doctoral degrees. The objective of this award is to facilitate a timely transition of these fellows from their mentored, postdoctoral research positions to independent tenure-track (or equivalent) faculty positions. The program will provide independent NCI research support during this transition to help awardees to launch competitive, independent research careers. Researchers in the scientific areas of cancer control, cancer prevention and cancer data sciences are especially encouraged to work with their institutions to apply. This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Under this NOFO candidates are permitted to propose a research experience in a clinical trial led by a mentor or co-mentor. Those proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion NOFOs (PAR-23-287 or PAR-23-288).

Eligibility

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Files

File Type Posted
PKG00289155.pdf PDF
PAR-23-286-Full-Announcement.html HTML file
PKG00283760.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity
Try for free Login